BIM
INFI

Bogle Investment Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Bogle Investment Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-219,652
Closed -$445K – 400
2017
Q4 		$445K Sell
219,652
-5,141
-2% -$10.7K 0.03% 249
2017
Q3 		$298K Sell
224,793
-6,500
-3% -$8.07K 0.02% 269
2017
Q2 		$363K Sell
231,293
-39,124
-14% -$75.5K 0.03% 268
2017
Q1 		$873K Sell
270,417
-332
-0.1% -$817 0.06% 235
2016
Q4 		$365K Sell
270,749
-70,341
-21% -$91.9K 0.03% 303
2016
Q3 		$532K Sell
341,090
-4,356
-1% -$6.69K 0.04% 295
2016
Q2 		$459K Sell
345,446
-6,343
-2% -$29.7K 0.03% 328
2016
Q1 		$1.85M Buy
351,789
+171,180
+95% +$1.05M 0.12% 178
2015
Q4 		$1.42M Sell
180,609
-288,436
-61% -$2.48M 0.1% 231
2015
Q3 		$3.96M Buy
469,045
+413,821
+749% +$3.82M 0.28% 125
2015
Q2 		$604K Sell
55,224
-406,678
-88% -$5.22M 0.05% 300
2015
Q1 		$6.46M Hold
461,902
– – 0.44% 81
2014
Q4 		$7.8M Sell
461,902
-5,589
-1% -$81.4K 0.52% 73
2014
Q3 		$6.27M Buy
+467,491
New +$5.57M 0.41% 98

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Bogle Investment Management's INFI Position: Q1 2018 in Review

Bogle Investment Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2018, closing a stake of 219,652 shares — an estimated $445K sold.

Bogle Investment Management first reported a position in INFI in Q3 2014 and held it in 14 quarters. The position peaked at $7.8M in Q4 2014. 66 funds tracked by Wall St. Rank hold INFI as of Q1 2018.

  • Bogle Investment Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Bogle Investment Management sold 219,652 Infinity Pharmaceuticals, Inc. shares in Q1 2018, an estimated $445K.
  • Bogle Investment Management first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2014 and held it in 14 quarters.
  • Bogle Investment Management's Infinity Pharmaceuticals, Inc. position peaked at $7.8M in Q4 2014.
  • 66 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2018.

Based on Bogle Investment Management's 13F filing for Q1 2018, filed 14 May 2018.